Leflunomide Overview Categories 2 Analgesics, antipyretics, NSAIDs, antigout, and antirheumatics2.4 Disease modifying antirheumatic drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Leflunomide Manufacturers of Leflunomide Primary Characterstics It is of Synthetic origin and belongs to Pyrimidine synthes inhibitor. . The Molecular Weight of Leflunomide is 270.23. Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Leflunomide's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 100 mg100 (100)24 hourlyPOFor 3 days. Then 10-20 mg QD for maintenance. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Leflunomide is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Leflunomide is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Leflunomide Back to top Manufacturers of Leflunomide in Pakistan Barrett Biogenics Biolabs Bosch Caraway English Everest Genix Genome Getz Global Hilton Innvotek Lexicon Macter Mass Medizan Lab Nexus Noa Hemis Panacea Pharmevo Pharmix Rotex S.J.& G Scotmann Searle Valor Wilshire WnsFeild Back to top Previous Drug Generic - Next Drug Generic
Leflunomide Overview Categories 2 Analgesics, antipyretics, NSAIDs, antigout, and antirheumatics2.4 Disease modifying antirheumatic drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Leflunomide Manufacturers of Leflunomide Primary Characterstics It is of Synthetic origin and belongs to Pyrimidine synthes inhibitor. . The Molecular Weight of Leflunomide is 270.23. Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Leflunomide's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 100 mg100 (100)24 hourlyPOFor 3 days. Then 10-20 mg QD for maintenance. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Leflunomide is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Leflunomide is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Leflunomide Back to top Manufacturers of Leflunomide in Pakistan Barrett Biogenics Biolabs Bosch Caraway English Everest Genix Genome Getz Global Hilton Innvotek Lexicon Macter Mass Medizan Lab Nexus Noa Hemis Panacea Pharmevo Pharmix Rotex S.J.& G Scotmann Searle Valor Wilshire WnsFeild Back to top Previous Drug Generic - Next Drug Generic